OSAKA, Japan & HEIDELBERG, Germany & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Fifth paragraph, the number in the quote should read: 10 million units sold instead of 10,000 million units sold.
Prezista (darunavir) : Janssen Sc. Ireland vs. Amneal Pharma
Prolensa (Bromfenac) : Senju Pharmaceutical, Bausch & Lomb Pharma vs. Amneal Pharmaceuticals
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
Jublia (efinaconazole topical solution) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals
Montreal based biotech company, SemaThera Inc. recently announced the closing of a $2 million co-investment from Senju Pharmaceutical Co., Ltd. and AmorChem L.P. for the development of its lead candidate, ST-102, in preparation for a clinical trial application in diabetic macular edema (DME).
SemaThera Announces a $2MUS Financing and a Licensing Deal for China and Japan
Allergan Inc., Senju Pharmaceutical Co. Ltd. and Kyorin Pharmaceutical Co. Ltd. have agreed to pay Hartig Drug Co. Inc. $9 million to end a putative class action alleging product-hopping over eye care products Zymar and Zymaxid, according to documents filed Friday in Delaware federal court.